|
Press Releases |
|
|
|
Tuesday, May 28, 2024 |
|
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project |
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders. The data resulting from this project have been acquired by Boehringer Ingelheim, where this research will be continued, potentially paving the way for novel therapies. more info >> |
|
Thursday, May 16, 2024 |
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim |
XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. more info >> |
|
Tuesday, April 30, 2024 |
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
Tuesday, February 6, 2024 |
|
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine |
more info >> |
|
Friday, December 22, 2023 |
|
BioMed X 研究所與小野藥品公司(Ono Pharmaceutical)在癌症研究領域啟動新的合作 |
more info >> |
|
BioMed X 研究所与小野药品公司(Ono Pharmaceutical)在癌症研究领域启动新的合作 |
more info >> |
|
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research |
more info >> |
|
Tuesday, November 7, 2023 |
|
BioMed X Launches a New Call for Application in Autoimmune Disease Research |
more info >> |
|
Wednesday, November 1, 2023 |
|
BioMed X and AbbVie Start New Research Project in the USA |
more info >> |
|
Thursday, June 29, 2023 |
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 21, 2024 23:34 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 21, 2024 23:23 HKT/SGT
|
|
|
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 21:59 HKT/SGT
|
|
|
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry
Nov 21, 2024 21:29 HKT/SGT
|
|
|
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Nov 21, 2024 21:20 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 21:00: JST
|
|
|
Yahoo Finance Invest Asia 2024 - Disrupting Finance: Innovations Shaping The Future
Nov 21, 2024 20:45 HKT/SGT
|
|
|
BIP Asia Forum and Entrepreneur Day Returns in December
Nov 21, 2024 20:30 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 20:19 HKT/SGT
|
|
|
SGX-Listed Mooreast Appoints Norwegian Eirik Ellingsen as CEO to Drive Growth in Global Floating Offshore Wind Market
Nov 21, 2024 20:00: JST
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 21, 2024 19:51 HKT/SGT
|
|
|
透云生物莱茵衣藻获国家卫健委新用途许可
Nov 21, 2024 19:33 HKT/SGT
|
|
|
SGX-Listed Mooreast Appoints Norwegian Eirik Ellingsen as CEO to Drive Growth in Global Floating Offshore Wind Market
Nov 21, 2024 19:00 HKT/SGT
|
|
|
DesignInspire opens on December 5, with free admission for the public
Nov 21, 2024 17:54 HKT/SGT
|
|
|
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
|
|
|
|
More News >> |
|
|
|
|
|